ClinicalTrials.gov
ClinicalTrials.gov Menu

Dual REctcal Angiogenesis or MEK Inhibition radioTHERAPY Trial (DREAMtherapy)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01160926
Recruitment Status : Terminated (2 DLTs had been reported from first 4 patients on lowest possible dose cohort.)
First Posted : July 13, 2010
Last Update Posted : January 27, 2016
Sponsor:
Collaborators:
Cancer Research UK
AstraZeneca
Information provided by (Responsible Party):
Suzanne Rowland, Christie Hospital NHS Foundation Trust

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : October 2013
  Estimated Study Completion Date : September 2016